The9 opened higher at $2.73, compared with its previous close of $2.72. In the last trading session, the stock traded between $2.57 and $2.77. It showed a sideways intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in The9 is now worth
$ 2.34
Resulting in a loss of
$ 97.66 (97.66%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
No analyst rating data available.
Markets Today
Today's Change
$-0.02 (-0.63%)
Day High
$2.77
Day Low
$2.57
Day Open
$2.73
Prev Close
$2.72
Volume
13,971
1W Return
6.21%
1M Return
-24.26%
3M Return
-35.33%
6M Return
-58.48%
1Y Return
-64.80%
Fundamentals
Market Cap ($ Mn)
41
PE Ratio
-
PB Ratio
0.68
PEG Ratio
-
ROE
-103.53%
ROCE
-100.41%
EPS (TTM)
-
Investment Returns
1 Week
6.21%
1 Month
-24.26%
3 Months
-35.33%
6 Months
-58.48%
9 Months
-54.49%
Financials
Quarterly
All values in $ Mn
54.8
Jun 12
26.2
Jun 13
37.0
Mar 25
25.1
Jun 25
12.8
Mar 26
4.8
Jun 26
Updates
24Aug
The9 Q2 Results: EPS $0.01, sales $712,000
The9 reported quarterly EPS of $0.01. Sales for the quarter stood at $712,000. No prior-period comparisons were disclosed.
2mo ago
21Aug
The9 investee Nanyang Biologics clears vote for Nasdaq listing
RF Acquisition Corp II shareholders approved the business combination with Nanyang Biologics on August 19, 2026. The9 expects to hold approximately 15% to 16% of the combined Nasdaq-listed company. Nanyang Biologics plans to trade under the ticker symbol "NYB". The transaction remains subject to customary closing conditions.
2mo ago
27Jul
The9 reports record US$23M Q1 net income on 9BIT token gains
The9 Limited achieved a record net income of US$23 million in Q1FY26, primarily due to the receipt of 1.425 billion 9BIT tokens valued at fair market prices. With an additional 475 million tokens received in April, total allocations under the 9BIT Foundation agreement reach approximately 1.9 billion tokens. The company's total crypto holdings are valued at roughly US$110 million.
